• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国围绝经期和绝经后女性血管舒缩症状的发生频率及严重程度。

Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.

作者信息

Williams R E, Kalilani L, DiBenedetti D Britt, Zhou X, Granger A L, Fehnel S E, Levine K B, Jordan J, Clark R V

机构信息

Worldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, NC 27709-3398, USA.

出版信息

Climacteric. 2008 Feb;11(1):32-43. doi: 10.1080/13697130701744696.

DOI:10.1080/13697130701744696
PMID:18202963
Abstract

OBJECTIVE

To describe characteristics of vasomotor symptoms, specifically daily frequency and severity, among women 40-65 years old in the United States (US).

DESIGN

A survey was completed by a nationally representative sample of 4402 US women aged 40-65 years old. A questionnaire focusing on menopausal symptoms was administered online in April 2005.

RESULTS

The prevalence of vasomotor symptoms was 79% in peri- and 65% in postmenopausal women. Women with daily vasomotor symptoms had an average of 2.5 very mild/mild, 2.6 moderate, 2.5 severe, and 1.4 very severe daytime hot flushes in a typical day. Women with night sweats every night had an average of 2.4 moderate, 3.2 severe, and 2.7 very severe night sweats in a typical night. Overall, 9% of peri- and 7% of postmenopausal women reported 7+ moderate to very severe vasomotor symptoms in a typical day. Although some women reported that symptoms were worse in the evening and in the summer, many women reported they were consistent, both throughout the day and throughout the seasons of the year.

CONCLUSIONS

The Menopause Epidemiology Study builds upon existing literature by providing data on daily frequency and severity of vasomotor symptoms. There are many women with frequent and severe vasomotor symptoms who may benefit from treatment.

摘要

目的

描述美国40 - 65岁女性血管舒缩症状的特征,特别是每日发作频率和严重程度。

设计

对4402名年龄在40 - 65岁的美国女性进行了一项全国代表性抽样调查。2005年4月通过在线方式发放了一份聚焦更年期症状的问卷。

结果

血管舒缩症状的患病率在围绝经期女性中为79%,在绝经后女性中为65%。有每日血管舒缩症状的女性在典型的一天中,平均有2.5次非常轻微/轻微、2.6次中度、2.5次重度和1.4次非常重度的日间潮热。每晚有盗汗的女性在典型的一晚中,平均有2.4次中度、3.2次重度和2.7次非常重度的盗汗。总体而言,9%的围绝经期女性和7%的绝经后女性报告在典型的一天中有7次及以上中度至非常重度的血管舒缩症状。尽管一些女性报告症状在晚上和夏季更严重,但许多女性表示症状在一整天和一年的各个季节中都是持续的。

结论

更年期流行病学研究通过提供血管舒缩症状的每日发作频率和严重程度的数据,对现有文献进行了补充。有许多血管舒缩症状频繁且严重的女性可能会从治疗中受益。

相似文献

1
Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States.美国围绝经期和绝经后女性血管舒缩症状的发生频率及严重程度。
Climacteric. 2008 Feb;11(1):32-43. doi: 10.1080/13697130701744696.
2
Severity of menopausal symptoms of Jordanian women.约旦女性的更年期症状严重程度。
Climacteric. 2010 Aug;13(4):385-94. doi: 10.3109/13697130903050009.
3
MF-101, an estrogen receptor beta agonist for the treatment of vasomotor symptoms in peri- and postmenopausal women.MF-101,一种用于治疗绝经前后女性血管舒缩症状的雌激素受体β激动剂。
Curr Opin Investig Drugs. 2009 Apr;10(4):365-71.
4
Severe hot flashes are associated with chronic insomnia.严重潮热与慢性失眠有关。
Arch Intern Med. 2006 Jun 26;166(12):1262-8. doi: 10.1001/archinte.166.12.1262.
5
Menopausal symptoms in a hospital-based sample of women in southern Thailand.泰国南部某医院女性样本中的更年期症状
Climacteric. 2006 Feb;9(1):23-9. doi: 10.1080/13697130500487422.
6
The menopausal experience among indigenous women of Sarawak, Malaysia.马来西亚沙捞越州本土女性的更年期经历。
Climacteric. 2009 Dec;12(6):548-56. doi: 10.3109/13697130902919519.
7
Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life.接受乳腺癌治疗的女性的更年期症状:症状的患病率和严重程度及其对生活质量的感知影响。
Climacteric. 2006 Feb;9(1):49-58. doi: 10.1080/13697130500487224.
8
Vasomotor symptoms are associated with a lower bone mineral density.血管舒缩症状与较低的骨矿物质密度相关。
Menopause. 2009 Mar-Apr;16(2):231-8. doi: 10.1097/gme.0b013e318185e25b.
9
Self-reported anxiety, depressive, and vasomotor symptoms: a study of perimenopausal women presenting to a specialized midlife assessment center.自述的焦虑、抑郁和血管舒缩症状:向专门的中年评估中心就诊的围绝经期妇女的研究。
Menopause. 2010 Mar;17(2):410-5. doi: 10.1097/gme.0b013e3181bf5a62.
10
Menopause-specific questionnaire assessment in US population-based study shows negative impact on health-related quality of life.在美国基于人群的研究中,更年期特异性问卷调查评估显示对健康相关生活质量有负面影响。
Maturitas. 2009 Feb 20;62(2):153-9. doi: 10.1016/j.maturitas.2008.12.006. Epub 2009 Jan 21.

引用本文的文献

1
Androgens for genitourinary and vasomotor symptoms associated with menopause.用于治疗与绝经相关的泌尿生殖系统症状和血管舒缩症状的雄激素。
Cochrane Database Syst Rev. 2025 Jun 17;6(6):CD016052. doi: 10.1002/14651858.CD016052.
2
Effects of menopause on temperature regulation.更年期对体温调节的影响。
Temperature (Austin). 2025 Apr 23;12(2):92-132. doi: 10.1080/23328940.2025.2484499. eCollection 2025.
3
Comparison of Symptoms Between Midlife Women in Perimenopause and Postmenopause Using Network Comparison Test.使用网络比较测试对围绝经期和绝经后期中年女性的症状进行比较
West J Nurs Res. 2025 Jul;47(7):630-640. doi: 10.1177/01939459251333669. Epub 2025 Apr 12.
4
Efficacy and safety of fezolinetant for moderate-severe vasomotor symptoms associated with menopause in individuals unsuitable for hormone therapy: phase 3b randomised controlled trial.非甾体选择性神经激肽 3(NK3)受体拮抗剂 fezolinetant 治疗不适合激素治疗的绝经相关中重度血管舒缩症状的疗效和安全性:3b 期随机对照试验。
BMJ. 2024 Nov 18;387:e079525. doi: 10.1136/bmj-2024-079525.
5
Menopausal Vasomotor Symptoms and Subclinical Atherosclerotic Cardiovascular Disease: A Population-Based Study.绝经后血管舒缩症状与亚临床动脉粥样硬化性心血管疾病:一项基于人群的研究。
J Am Heart Assoc. 2024 Sep 3;13(17):e033648. doi: 10.1161/JAHA.123.033648. Epub 2024 Aug 21.
6
The association of vasomotor symptoms with fracture risk and bone mineral density in postmenopausal women: a systematic review and meta-analysis of observational studies.绝经后妇女血管舒缩症状与骨折风险和骨密度的关系:观察性研究的系统评价和荟萃分析。
Osteoporos Int. 2024 Aug;35(8):1329-1336. doi: 10.1007/s00198-024-07075-8. Epub 2024 Apr 2.
7
Fezolinetant treatment of moderate-to-severe vasomotor symptoms due to menopause: effect of intrinsic and extrinsic factors in two phase 3 studies (SKYLIGHT 1 and 2).非佐利奈坦治疗绝经相关中重度血管舒缩症状:两项 3 期研究(SKYLIGHT 1 和 2)中内在和外在因素的影响。
Menopause. 2024 Apr 1;31(4):247-257. doi: 10.1097/GME.0000000000002340.
8
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause.接受治疗与未接受治疗的绝经后血管舒缩症状女性的医疗费用比较。
Adv Ther. 2024 May;41(5):1885-1895. doi: 10.1007/s12325-024-02821-0. Epub 2024 Mar 11.
9
Disturbed sleep is associated with reduced verbal episodic memory and entorhinal cortex volume in younger middle-aged women with risk-reducing early ovarian removal.有卵巢切除术风险的年轻中年女性中,睡眠紊乱与言语情节记忆减退和内嗅皮层体积减少有关。
Front Endocrinol (Lausanne). 2023 Oct 3;14:1265470. doi: 10.3389/fendo.2023.1265470. eCollection 2023.
10
Premenstrual Disorders, Timing of Menopause, and Severity of Vasomotor Symptoms.经前期障碍、绝经时间与血管舒缩症状严重程度。
JAMA Netw Open. 2023 Sep 5;6(9):e2334545. doi: 10.1001/jamanetworkopen.2023.34545.